4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-22-015535
Chief Financial Officer gave up 3,044 shares (to pay taxes)
- Chief Financial Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2022-06-16 | Option exercise | +12,500 | 14,167 | D | ||
| Foster Jonathan P. Chief Financial Officer | 2022-06-16 | Shares withheld for taxes | −3,044 | $1.33 | $4,049 | 11,123 | D |
| Derivatives | |||||||
| Foster Jonathan P. Chief Financial Officer | 2022-06-16 | Option exercise · Restricted Stock Units | −12,500 | 416,438 | D | ||
Loading xslF345X03/rdgdoc.xml…